Top 0.01% — Titan Historical Figure
Jonas Salk
United States
45 H-Index
2,185 Citations
597 Total Impact
GLLasker Award for Clinical Medical Research (1956)0
NHPresidential Medal of Freedom (1977)0
NHCongressional Gold Medal (1975)0
Overview
Jonas Salk was a virology and vaccine development specialist with an H-index of 45 at the University of Pittsburgh and the Salk Institute for Biological Studies. Developed the first successful inactivated polio vaccine (1955) and refused to patent it. Based in United States.
For Patients
- Pioneered 2 medical techniques including Inactivated (killed-virus) polio vaccine (Salk vaccine) and Formaldehyde inactivation method for poliovirus
- Research was cited 2K+ times by other doctors and scientists
- Based at University of Pittsburgh School of Medicine in United States
Biography
Jonas Salk was an American virologist and medical researcher who developed the first successful inactivated polio vaccine in 1955, helping to prevent a disease that had paralyzed thousands each year. He famously refused to patent the vaccine, forgoing an estimated $7 billion in personal profit, and later founded the Salk Institute for Biological Studies in La Jolla, California.
Affiliations & Institutions
Research Impact
10 Publications
2,185 Total Citations
1K+ Citation Milestone
Publication Timeline
Published In
The Journal of ImmunologyArchives of Biochemistry and BiophysicsJournal of the American Medical AssociationScienceAmerican Journal of Public Health and the Nations Health
Key Publications
A Simplified Procedure for Titrating Hemagglutinating Capacity of Influenza-Virus and the Corresponding Antibody
Experimental allergic encephalomyelitis
STUDIES IN HUMAN SUBJECTS ON ACTIVE IMMUNIZATION AGAINST POLIOMYELITIS
A Strategy for Prophylactic Vaccination Against HIV
Control of Influenza and Poliomyelitis with Killed Virus Vaccines
Areas of Expertise
Pioneering Techniques
Medical Specialties
Clinical Knowledge & Procedures
Legacy Timeline
The life and contributions of Jonas Salk
1947
Began polio research at the University of Pittsburgh
1952
First human trials of inactivated polio vaccine
1955
Polio vaccine declared safe and effective after nationwide field trial
1963